These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 29779801)
41. The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta-analysis. Cooper RE; Tye C; Kuntsi J; Vassos E; Asherson P J Affect Disord; 2016 Jan; 190():474-482. PubMed ID: 26551407 [TBL] [Abstract][Full Text] [Related]
42. [Omega-3 and omega-6 fatty acids in the treatment of children and adolescents with ADHD]. Aben A; Danckaerts M Tijdschr Psychiatr; 2010; 52(2):89-97. PubMed ID: 20146180 [TBL] [Abstract][Full Text] [Related]
43. Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Raz R; Gabis L Dev Med Child Neurol; 2009 Aug; 51(8):580-92. PubMed ID: 19549202 [TBL] [Abstract][Full Text] [Related]
44. The diet factor in attention-deficit/hyperactivity disorder. Millichap JG; Yee MM Pediatrics; 2012 Feb; 129(2):330-7. PubMed ID: 22232312 [TBL] [Abstract][Full Text] [Related]
45. The effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder-a placebo-controlled double-blind study. Hamazaki T; Hirayama S Eur J Clin Nutr; 2004 May; 58(5):838. PubMed ID: 15116088 [No Abstract] [Full Text] [Related]
46. [The role of zinc in the treatment of hyperactivity disorder in children]. Dodig-Curković K; Dovhanj J; Curković M; Dodig-Radić J; Degmecić D Acta Med Croatica; 2009 Oct; 63(4):307-13. PubMed ID: 20034331 [TBL] [Abstract][Full Text] [Related]
47. The influence of comorbid asthma on the severity of symptoms in children with attention-deficit hyperactivity disorder. Borschuk AP; Rodweller C; Salorio CF J Asthma; 2018 Jan; 55(1):66-72. PubMed ID: 28459608 [TBL] [Abstract][Full Text] [Related]
48. Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder. Arnold LE; Bozzolo H; Hollway J; Cook A; DiSilvestro RA; Bozzolo DR; Crowl L; Ramadan Y; Williams C J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):628-36. PubMed ID: 16190794 [TBL] [Abstract][Full Text] [Related]
49. Polyunsaturated fatty acid supplementation for ADHD? Fishy, fascinating, and far from clear. Busch B J Dev Behav Pediatr; 2007 Apr; 28(2):139-44. PubMed ID: 17435465 [No Abstract] [Full Text] [Related]
50. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Burgess JR; Stevens L; Zhang W; Peck L Am J Clin Nutr; 2000 Jan; 71(1 Suppl):327S-30S. PubMed ID: 10617991 [TBL] [Abstract][Full Text] [Related]
51. Attention-deficit/hyperactivity disorder: evidence-based diagnosis and management for primary care clinicians. Liu YH; Stein MT Minerva Pediatr; 2004 Dec; 56(6):567-83. PubMed ID: 15765020 [TBL] [Abstract][Full Text] [Related]
52. Choice-impulsivity in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): A meta-analytic review. Patros CH; Alderson RM; Kasper LJ; Tarle SJ; Lea SE; Hudec KL Clin Psychol Rev; 2016 Feb; 43():162-74. PubMed ID: 26602954 [TBL] [Abstract][Full Text] [Related]
53. Current evidence and future directions for research with omega-3 fatty acids and attention deficit hyperactivity disorder. Gow RV; Hibbeln JR; Parletta N Curr Opin Clin Nutr Metab Care; 2015 Mar; 18(2):133-8. PubMed ID: 25581035 [TBL] [Abstract][Full Text] [Related]
54. Satiety regulation in children with loss of control eating and attention-deficit/hyperactivity disorder: A test meal study. Kurz S; Schoebi D; Dremmel D; Kiess W; Munsch S; Hilbert A Appetite; 2017 Sep; 116():90-98. PubMed ID: 28428150 [TBL] [Abstract][Full Text] [Related]
55. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Sorgi PJ; Hallowell EM; Hutchins HL; Sears B Nutr J; 2007 Jul; 6():16. PubMed ID: 17629918 [TBL] [Abstract][Full Text] [Related]
56. Bifactor latent structure of attention-deficit/hyperactivity disorder (ADHD)/oppositional defiant disorder (ODD) symptoms and first-order latent structure of sluggish cognitive tempo symptoms. Lee S; Burns GL; Beauchaine TP; Becker SP Psychol Assess; 2016 Aug; 28(8):917-28. PubMed ID: 26502205 [TBL] [Abstract][Full Text] [Related]
57. Effect of n-3 supplementation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit-hyperactivity disorder. Hariri M; Djazayery A; Djalali M; Saedisomeolia A; Rahimi A; Abdolahian E Malays J Nutr; 2012 Dec; 18(3):329-35. PubMed ID: 24568073 [TBL] [Abstract][Full Text] [Related]
58. The Effect of Experimental Supplementation with the Klamath Algae Extract Klamin on Attention-Deficit/Hyperactivity Disorder. Cremonte M; Sisti D; Maraucci I; Giribone S; Colombo E; Rocchi MBL; Scoglio S J Med Food; 2017 Dec; 20(12):1233-1239. PubMed ID: 29116873 [TBL] [Abstract][Full Text] [Related]
59. Prevalence of probable Attention-Deficit/Hyperactivity Disorder symptoms: result from a Spanish sample of children. Cerrillo-Urbina AJ; García-Hermoso A; Martínez-Vizcaíno V; Pardo-Guijarro MJ; Ruiz-Hermosa A; Sánchez-López M BMC Pediatr; 2018 Mar; 18(1):111. PubMed ID: 29544457 [TBL] [Abstract][Full Text] [Related]
60. Physical fatty acid deficiency signs in children with ADHD symptoms. Sinn N Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):109-15. PubMed ID: 17825546 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]